SC-CAR.GPC3xIL15.21 CAR T cells / Seattle Children's Hospital - LARVOL DELTA

IMPACT: Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells (clinicaltrials.gov) - P1 | N=21 | Recruiting | Sponsor: Seattle Children's Hospital | Not yet recruiting ➔ Recruiting

Enrollment open • CNS Tumor • Hepatoblastoma • Hepatocellular Cancer • Liposarcoma • Nephrology • Oncology • Pediatrics • Rhabdoid Tumor • Rhabdomyosarcoma • Sarcoma • Solid Tumor • Wilms Tumor

INTERCEPT: Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors (clinicaltrials.gov) - P1 | N=21 | Not yet recruiting | Sponsor: Seattle Children's Hospital

New P1 trial • Hepatocellular Cancer • Liposarcoma • Oncology • Rhabdomyosarcoma • Sarcoma • Solid Tumor